Introduction of platelet additive solutions in transfusion practice. Advantages, disadvantages and benefit for patients;Introduction en pratique transfusionnelle des concentrés de plaquettes en solution de conservation. Avantages, inconvénients, et intérêt pour les patients

Transfusion Clinique et Biologique

Volumn 14, Issue 1, 2007, Pages 100-106

  Andreu, Georges ^a   Vasse, Julie ^b   Hervé, Françoise ^b   Tardivel, René ^b   Semana, Gilbert ^b  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^b ETS de Bretagne   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; CITRIC ACID; GLUCONATE SODIUM; GLUCOSE; MAGNESIUM; POTASSIUM; SODIUM DIHYDROGEN PHOSPHATE; TRICARBOXYLIC ACID;

BLOOD GROUP ABO INCOMPATIBILITY; CLINICAL PRACTICE; COST BENEFIT ANALYSIS; HUMAN; SHORT SURVEY; THROMBOCYTE METABOLISM; THROMBOCYTE TRANSFUSION;

ACETATES; BLOOD GLUCOSE; BLOOD PRESERVATION; CITRATES; HUMANS; MAGNESIUM; PHOSPHATES; PLATELET TRANSFUSION; POTASSIUM; PRESERVATIVES, PHARMACEUTICAL; SOLUTIONS; TREATMENT OUTCOME;

EID: 34249893077     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tracli.2007.03.009     Document Type: Short Survey

References (23)

1. Rock G., Swenson S.D., and Adams G.A. Platelet storage in a plasma-free medium. Transfusion 25 (1985) 551-556
2. Adams G.A., Swenson S.D., and Rock G. Survival and recovery of human platelets stored for five days in a non-plasma medium. Blood 67 (1986) 672-675
3. Holme S., Heaton W.A., and Courtright M. Improved in vivo and in vitro viability of platelet concentrates stored for seven days in a platelet additive solution. Br J Haematol 66 (1987) 233-238
4. Kilkson H., Holme S., and Murphy S. Platelet metabolism during storage of platelet concentrates at 22 °C. Blood 64 (1984) 406-414
5. Whisson M.E., Nakhoul A., Howman P., et al. Quantitative study of starving platelets in a minimal medium: maintenance by acetate or plasma but not by glucose. Transfus Med 3 (1993) 103-113
6. Gawaz M., Ott I., Reiniger A.J., et al. Effects of magnesium on platelet aggregation and adhesion. Magnesium modulates surface expression of glycoproteins on platelets in vitro and ex vivo. Thromb Haemost 72 (1994) 912-918
7. Weis-Fogh U.S. The effect of citrate, calcium, and magnesium ions on the potassium movement across the human platelet membrane. Transfusion 25 (1985) 339-342
8. Ravn H.B., Vissinger H., Kristensen S.D., et al. Magnesium inhibits platelet activity: an in vitro study. Thromb Haemost 76 (1996) 88-93
9. De Wildt-Eggen J., Schrijver J.G., Bins M., et al. Storage of platelets in additive solutions: effects of magnesium and/or potassium. Transfusion 42 (2002) 76-80
10. Gulliksson H., AuBuchon J.P., Cardigan R., et al. Storage of platelets in additive solutions: a multicentre study of the in vitro effects of potassium and magnesium. Vox Sang 85 (2003) 199-205
11. Gulliksson H., AuBuchon J.P., Vesterinen M., et al. Storage of platelets in additive solutions: a pilot in vitro study of the effects of potassium and magnesium. Vox Sang 82 (2002) 131-136
12. Van der Meer P.F., Pietersz R.N.I., and Reesink H.W. Storage of platelets in additive solution for up to 12 days with maintenance of good in vitro quality. Transfusion 44 (2004) 1204-1211
13. Van der Meer P.F., Gulliksson H., AuBuchon J.P., et al. for the Biomedical Excellence for Safer Transfusion (BEST). Collaborative: Interruption of agitation of platelet concentrates: effects on in vitro parameters. Vox Sang 88 (2005) 227-234
14. de Wildt-Eggen J., Nauta S., Schrijver J.G., van Marwijk Kooy M., Bins M., and van Prooijen H.C. Reactions and platelets increments after transfusion of platelet concentrates in plasma or an additive solution: a prospective, randomised study. Transfusion 40 (2000) 398-403
15. Kerkhoffs J.L., Eikenboom J.C., Schipperus M.S., van Wordragen-Vlaswinkel R.J., Brand R., Harvey M.S., et al. A multicenter randomized study of the efficacy of transfusions with platelets stored in platelet additive solution II versus plasma. Blood 108 (2006) 3210-3215
16. van Rhenen D.J., Vermeij H., Kappers-Klunne M., and Payrat J.M. Evaluation of a new citrate-acetate-NaCl platelet additive solution for the storage of white cell-reduced platelet concentrates obtained from half-strength CPD pooled buffy coats. Transfusion 35 (1995) 50-53
17. van Rhenen D.J., Gulliksson H., Cazenave J.P., Pamphilon D., Davis K., Flament J., et al. Therapeutic efficacy of pooled buffy-coat platelet components prepared and stored with a platelet additive solution. Transfus Med 14 (2004) 289-295
18. Andreu G., Morel P., Forestier F., Debeir J., Rebibo D., Janvier G., et al. Haemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998. Transfusion 42 (2002) 1356-1364
19. Snyder E., McCullough J., Slichter S.J., Strauss R.G., Lopez-Plaza I., Lin J.S., et al. Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial. Transfusion 45 (2005) 1864-1875
20. Ringwald J., Walz S., Zimmermann R., et al. Hyper-concentrated platelets stored in additive solution: aspects on productivity and in vitro storage. Vox Sang 89 (2005) 11-18
21. Ringwald J., Althoff F., Zimmermann R., et al. Washing platelets with new additive solutions: aspects on the in vitro quality after 48 h of storage. Transfusion 46 (2006) 236-243
22. Rebibo D., Hauser L., Slimani A., Herve P., and Andreu G. The French Haemovigilance System : organization and results for 2003. Transfus Apheresis Sci 31 (2004) 145-153
23. Blumberg N., Heal J.M., and Rowe J.M. A randomized trial of washed red blood cell and platelet transfusions in adult acute leukaemia. BMC Blood Disord 4 (2004) 6